New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 7, 2012
10:05 EDTDST, SYT, AKR, ATHN, TSM, MPEL, AET, RHHBY, MCDOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Acadia Realty Trust (AKR) upgraded to Outperform from Market Perform at BMO Capital... McDonald's (MCD) upgraded to Buy from Neutral at Janney Capital... Melco Crown (MPEL) upgraded to Overweight from Neutral at JPMorgan... Syngenta (SYT) upgraded to Neutral from Underweight at JPMorgan...Roche (RHHBY) upgraded to Overweight from Equal Weight at Morgan Stanley... TSMC (TSM) upgraded to Outperform from Neutral at Credit Suisse... DST Systems (DST) upgraded to Buy from Neutral at Sterne Agee... Aetna (AET) upgraded to Overweight from Neutral at JPMorgan... athenahealth (ATHN) upgraded to Outperform from Market Perform at Leerink.
News For AKR;MCD;MPEL;SYT;RHHBY;TSM;DST;AET;ATHN From The Last 14 Days
Check below for free stories on AKR;MCD;MPEL;SYT;RHHBY;TSM;DST;AET;ATHN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
April 9, 2014
12:04 EDTSYTU.S. corn exports projected to increase 125M bushels
Subscribe for More Information
07:54 EDTATHNathenahealth earnings not impacted by OIG opinion, says Leerink
Subscribe for More Information
07:22 EDTATHNathenahealth confirms OIG terminates advisory opinion on HIE pricing
Subscribe for More Information
April 8, 2014
16:10 EDTRHHBYProthena says first human dosed in Phase 1 study of PRX002
Prothena (PRTA) announced the successful start of a Phase 1 clinical trial of its therapeutic monoclonal antibody candidate, PRX002, for the treatment of Parkinson's disease. Prothena has earned a $15M milestone payment from Roche (RHHBY) related to the initiation of this study. The initial Phase 1 clinical trial of PRX002 is a randomized, double-blind, placebo-controlled, single ascending dose study in healthy subjects. It is designed to assess PRX002 for safety, tolerability, pharmacokinetics and immunogenicity. As previously announced in December 2013, Prothena entered into a worldwide collaboration with Roche to develop and commercialize antibodies that target α-synuclein, including PRX002. Including the current milestone payment, Prothena has now achieved a total of $45M through its worldwide PRX002 collaboration with Roche.
11:03 EDTRHHBYPiper Jaffray's biopharm analyst holds an analyst/industry conference call
Biopharm Analyst Schimmer discusses PCSK9 Inhibitors and other atherosclerosis approaches on an Analyst/Industry conference call. Relevant companies AEGR, ALNY, AMGN, ARNA, AZN, BMY, CBST, LLY, ESPR, GSK, ICPT, ISIS, MNKD, MRK, OREX, PFE, REGN, RHHBY, SNY and VVUS may be included on the Analyst/Industry conference call to be held on April 10 at 3 pm.
10:18 EDTAETCMS says Medicare Advantage reimbursement to rise in 2015
Subscribe for More Information
09:23 EDTAETLeerink views final rates as favorable for MA plans
Subscribe for More Information
April 7, 2014
19:13 EDTAETCMS issues 2015 rate announcement for Medicare Advantage and Part D programs
Subscribe for More Information
06:20 EDTTSMReport: TSMC Solar to triple CIGS-thin PV module capacity, DigiTimes says
TSMC Solar will expand its annual production capacity to 120MWp from 40MWp in Q3, reports DigiTimes. Citing a Chinese-language Economic Daily News report, TSMS is currently at full capacity. Reference Link
06:07 EDTRHHBYRoche acquires IQuum for $450M
Subscribe for More Information
April 4, 2014
11:31 EDTATHNOptions with increasing implied volatility: ATHN K SAN
Subscribe for More Information
08:56 EDTATHNathenahealth volatility increases to 55
Subscribe for More Information
06:54 EDTMCDMcDonald's ceases work in Crimea, Reuters says
Subscribe for More Information
April 3, 2014
16:16 EDTTSMGlobalfoundries in lead to buy IBM chip plants, TSMC out of talks, WSJ says
IBM (IBM) has held talks with Globalfoundries, Intel (INTC) and Taiwan Semiconductor (TSM) regarding its semiconductor manufacturing operations, and Globalfoundries appears to be in the lead as the most likely potential buyer, according to The Wall Street Journal, citing people familiar with the matter. IBM initially asked for more than $2B and bids have come in "north of $1B," the report noted, adding that Intel is still involved, but TSMC has dropped out of the talks. Reference Link
15:49 EDTTSMGlobalfoundries in lead to buy IBM chip plants, TSMC out of talks, DJ says
IBM (IBM) also held talks with Intel (INTC), according to Dow Jones, citing sources.
10:03 EDTRHHBYRoche unit signs companion diagnostic agreement with Genmab
Ventana Medical Systems, a member of the Roche Group, announced that it has entered into an agreement with Genmab A/S for the development of companion diagnostic tools for Genmab's HuMax-TF-ADC antibody drug conjugate program. The TF assay will be developed for possible designation as the screening test in clinical trials involving HuMax-TF-ADC.
06:34 EDTMCDStates moving on minimum wage hikes, NY Times says
Since President Obama called for an increase in the federal minimum wage 14 months ago, seven states and Washington, DC have passed such an increase, according to The New York Times. Meanwhile, 34 other state legislatures have started debating the issue and activists in another eight states are looking to get proposals for minimum wage increases on voter ballots, the newspaper stated. Companies that could be affected by minimum wage increases include McDonald's (MCD), Burger King (BKW), Wendy's (WEN), Jack in the Box (JACK), Dunkin Donuts (DNKN), and Sonic Corporation (SONC). Reference Link
06:30 EDTTSMTSMC capacity booked to end of Q3, DigiTimes reports
TSMC's production capacity has been booked through the end of Q3, reports DigiTimes. According to industry sources, the booked capacity is due to orders from the handset solution and PC chip vendors. Reference Link
April 2, 2014
11:14 EDTATHNOptions with increasing implied volatility: ATHN ISRG MYL
07:10 EDTMCDEx-McDonald's store managers admit to withholding wages, Bloomberg says
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use